Pulling and analyzing existing medical data, with traditional methods, can take weeks or months for researchers to complete. A new generative AI tool can create those studies in minutes. Atropos ...

Academic health system Emory Healthcare has selected Atropos Health to implement a new decision-making tool for generating real-world data (RWD) evidence for clinicians. The tool is designed to ...

Atropos Health, a pioneer in translating real-world clinical data into personalized real-world evidence (RWE) and insights, today announced the publication of additional AI tools for patient ...

The Company is Also Forging Strategic Partnerships With Pharmaceutical Companies and Vertically Integrated Healthcare Companies to Drive Evidence Adoption in Oncology and other Specialty areas PALO ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed a ...

Atropos Health raised $33 million for its software that runs separate queries on smaller piles of health data to determine how patients react to treatments in the real-world. The drugs slow stomach ...

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical decision making, today announced a scientific, multi-layered process for ...

Atropos Health, a company that translates real-world clinical data (RWD) into real-world evidence, announced a strategic partnership with Ontada, a McKesson business involved in community oncology.

There’s more healthcare data flowing through the system now than ever before, thanks to new sources like EMRs and wearables, that are being collected daily. Yet, despite that, there’s still an ...

Atropos Health Creates World’s Largest Body of Medical Evidence, Alexandria, for Clinical Decision Support and LLM Training to Improve Patient, Life Science, and Medical Outcomes Alexandria now ...

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform and presenting rare disease AI algorithms at the 67th American Society of Hematology ...